19 news items
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
AEI
AKAN
AKTS
24 May 24
. (NASDAQ:MGNI) gained 12.3% to $12.43. B of A Securities analyst Omar Dessouky upgraded Magnite from Neutral to Buy and raised the price target
HC Wainwright & Co. Reiterates Buy on Immunocore Hldgs, Maintains $100 Price Target
IMCR
24 May 24
HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $100 price target.
Analyst Expectations For Immunocore Hldgs's Future
IMCR
24 May 24
0
Providing deeper insights, analysts have established 12-month price targets, indicating an average
Needham Reiterates Buy on Immunocore Hldgs, Maintains $81 Price Target
IMCR
24 May 24
Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.
Mizuho Maintains Buy on Immunocore Hldgs, Lowers Price Target to $88
IMCR
13 May 24
Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and lowers the price target from $90 to $88.
asid1r xmk70ciuwefbyalfk59wh4old11n
IMCR
9 May 24
Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from $63 to $67.
zea 44prgnu0vqgqgotb5lxlco654qocozbx1
IMCR
9 May 24
HC Wainwright & Co. analyst Patrick Trucchio maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price target from $90 to $100.
pqzvlz8nuyr2z0
IMCR
9 May 24
Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.
aedx80h56g11dzq0fp5nqwjstg9gy2hd afhi8y8hj5p3qi8v
IMCR
29 Apr 24
0
Insights from analysts' 12-month price targets are revealed, presenting an average target of $81.4, a high
frtrrm69101kkrcp6z9n
IMCR
29 Apr 24
Leerink Partners analyst Jonathan Chang initiates coverage on Immunocore Hldgs (NASDAQ:IMCR) with a Outperform rating and announces Price Target of $74.
9jiixjsd4m5n3467zjfqbh2ayzsyj5t8h2ch is2qd60nva
IMCR
23 Apr 24
Guggenheim analyst Michael Schmidt reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $92 price target.
8lirvjx1chzvpglkxfsaty4gezoyorcoh6prrciog2x3j8
IMCR
11 Apr 24
0
Analysts have recently evaluated Immunocore Hldgs and provided 12-month price targets. The average
18ps1h2zmo3u4o5g1d3d8tc4jgnspvn5oonyeleo80sp
IMCR
11 Apr 24
Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $81 price target.
bdj6tv62qbg08tjgpc0n28fsmevpxpmw3qsb0br
IMCR
21 Mar 24
JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and raises the price target from $60 to $70.
8e920s
IMCR
5 Mar 24
a major barrier to therapeutic targeting Presenting author: Zoe WallaceSession: HIV immunotherapy
ad94z5k7864sn
IMCR
5 Mar 24
Mizuho analyst Graig Suvannavejh maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price target from $86 to $90.
xrp5i8iamqvb27df2xik6o3ug0efj6k7d7trzqv
IMCR
29 Feb 24
0
Providing deeper insights, analysts have established 12-month price targets, indicating an average target
pqcqgecauofu0ozzc64a8av28nsxqoocca7l8
IMCR
29 Feb 24
Oppenheimer analyst Justin Kim reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Outperform and raises the price target from $85 to $87.
nf1eg4bt4mlfmcxfwxlxksijwtiebq6c616nqr0uedlp7mx
IMCR
29 Feb 24
Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from $60 to $63.
- Prev
- 1
- Next